CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Help viewing high resolution images
Right arrow Return to article


Fig. 6. Under reduced serum conditions, JunD levels increase in AKR-2B cells. Subconfluent cultures of murine AKR-2B cells were incubated in growth medium supplemented with 10% (Lanes 1, 3, 5, and 7) or 1% FBS (Lanes 2, 4, 6, and 8) for 1 day (Lanes 1 and 2), 2 days (Lanes 3 and 4), 3 days (Lanes 5 and 6), and 4 days (Lanes 7 and 8). Nuclear extracts were prepared, and extracts containing equal amounts of proteins were analyzed by immunoblotting using the anti-JunD antibody. The same membrane was subsequently probed with antibodies to ß-actin (bottom panel) to control loading of equal amounts of proteins in the lanes. An arrow indicates the JunD protein band.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation